Trials / Completed
CompletedNCT04648878
A Comparison of Conventional Physical Therapy, Powered Exoskeleton, and Hybrid Physical Therapy With Exoskeleton
A Comparison of Conventional Physical Therapy, Powered Exoskeleton, and Hybrid Physical Therapy With Exoskeleton in the Treatment of Individuals With Sub-acute and Chronic Stroke.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this investigator-initiated study is to establish if powered exoskeleton therapy as a part of a rehabilitation program can be used as a standard of care in stroke rehabilitation.
Detailed description
This prospective randomized control trial with three treatment arms will begin by: * Determining if the subject is a candidate for exoskeleton treatment. * Randomly assigning subjects to three groups (physical therapy only, exoskeleton only, or a hybrid of physical therapy and exoskeleton). * Body measurements to individualize the fit of the exoskeleton to each subject at each session. * Activities-based balance confidence (ABC) questionnaire will be administered before and after the study begins. * Timed up and go test (TUGT). * Ten-meter walk test (10MWT). * Six-minute walk test (6MWT) * Berg Balance Test (BBT). * Five times sit to stand (5XSTS). * Heart rate through a portable heartrate monitor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hybrid combination of physical therapy and powered exoskeleton | 18 alternating visits of conventional physical therapy and powered exoskeleton gait training with a wearable robotic powered exoskeleton , three times a week for approximately 6 weeks |
| OTHER | Powered Exoskeleton Only | 18 visits of powered exoskelton only, three times a week for approximately 6 weeks |
| OTHER | Physical Therapy only | 18 visits of physical therapy only, three times a week for approximately 6 weeks |
Timeline
- Start date
- 2021-02-14
- Primary completion
- 2024-11-20
- Completion
- 2024-12-18
- First posted
- 2020-12-02
- Last updated
- 2025-03-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04648878. Inclusion in this directory is not an endorsement.